George Kemble - Net Worth and Insider Trading
George Kemble Net Worth
The estimated net worth of George Kemble is at least $602,960 dollars as of 2024-12-27. George Kemble is the Executive Chairman of Sagimet Biosciences Inc and owns about 118,693 shares of Sagimet Biosciences Inc (SGMT) stock worth over $602,960. Details can be seen in George Kemble's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that George Kemble has not made any transactions after 2024-07-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of George Kemble
George Kemble Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, George Kemble owns 1 companies in total, including Sagimet Biosciences Inc (SGMT) .
Click here to see the complete history of George Kemble’s form 4 insider trades.
Insider Ownership Summary of George Kemble
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SGMT | Sagimet Biosciences Inc | 2024-07-23 | director |
George Kemble Latest Holdings Summary
George Kemble currently owns a total of 1 stock. George Kemble owns 118,693 shares of Sagimet Biosciences Inc (SGMT) as of July 23, 2024, with a value of $602,960.
Latest Holdings of George Kemble
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGMT | Sagimet Biosciences Inc | 2024-07-23 | 118,693 | 5.08 | 602,960 |
Holding Weightings of George Kemble
George Kemble Form 4 Trading Tracker
According to the SEC Form 4 filings, George Kemble has made a total of 2 transactions in Sagimet Biosciences Inc (SGMT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Sagimet Biosciences Inc is the sale of 23,625 shares on July 23, 2024, which brought George Kemble around $74,891.
Insider Trading History of George Kemble
- 1
George Kemble Trading Performance
George Kemble Ownership Network
George Kemble Owned Company Details
What does Sagimet Biosciences Inc do?
Who are the key executives at Sagimet Biosciences Inc?
George Kemble is the director of Sagimet Biosciences Inc. Other key executives at Sagimet Biosciences Inc include General Counsel and CCO Elizabeth Rozek , director & President & CEO David Happel , and 10 percent owner New Enterprise Associates 13 Lp .
Sagimet Biosciences Inc (SGMT) Insider Trades Summary
Over the past 18 months, George Kemble made 2 insider transaction in Sagimet Biosciences Inc (SGMT) with a net sale of 37,687. Other recent insider transactions involving Sagimet Biosciences Inc (SGMT) include a net purchase of 14,290 shares made by David Happel , a net purchase of 29,338 shares made by New Enterprise Associates 13 Lp , and a net purchase of 46,875 shares made by Beth C Seidenberg .
In summary, during the past 3 months, insiders sold 0 shares of Sagimet Biosciences Inc (SGMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 57,620 shares of Sagimet Biosciences Inc (SGMT) were sold and 91,165 shares were bought by its insiders, resulting in a net purchase of 33,545 shares.
Sagimet Biosciences Inc (SGMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sagimet Biosciences Inc Insider Transactions
George Kemble Mailing Address
Above is the net worth, insider trading, and ownership report for George Kemble. You might contact George Kemble via mailing address: Sagimet Biosciences Inc., 155 Bovet Rd., Ste. 303, San Mateo Ca 94402.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
